| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 0.1 |